Pulmatrix Net Income vs. Revenue
Will Pharmaceuticals sector continue expanding? Could Pulmatrix diversify its offerings? Factors like these will boost the valuation of Pulmatrix. Anticipated expansion of Pulmatrix directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Pulmatrix data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (1.71) | Revenue Per Share | Quarterly Revenue Growth (1.00) | Return On Assets | Return On Equity |
The market value of Pulmatrix is measured differently than its book value, which is the value of Pulmatrix that is recorded on the company's balance sheet. Investors also form their own opinion of Pulmatrix's value that differs from its market value or its book value, called intrinsic value, which is Pulmatrix's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Pulmatrix's market value can be influenced by many factors that don't directly affect Pulmatrix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Pulmatrix's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Pulmatrix should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Pulmatrix's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Pulmatrix Revenue vs. Net Income Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Pulmatrix's current stock value. Our valuation model uses many indicators to compare Pulmatrix value to that of its competitors to determine the firm's financial worth. Pulmatrix is regarded fourth in net income category among its peers. It is regarded second in revenue category among its peers . Pulmatrix reported last year Net Loss of (8.6 Million). Comparative valuation analysis is a catch-all technique that is used if you cannot value Pulmatrix by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Pulmatrix Revenue vs. Net Income
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Pulmatrix |
| = | (9.56 M) |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Pulmatrix |
| = | 7.81 M |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Pulmatrix Revenue vs Competition
Pulmatrix is regarded second in revenue category among its peers. Market size based on revenue of Health Care industry is at this time estimated at about 21.25 Million. Pulmatrix totals roughly 7.81 Million in revenue claiming about 37% of equities under Health Care industry.
Pulmatrix Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Pulmatrix, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Pulmatrix will eventually generate negative long term returns. The profitability progress is the general direction of Pulmatrix's change in net profit over the period of time. It can combine multiple indicators of Pulmatrix, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -1.9 M | -2 M | |
| Operating Income | -8.8 M | -9.2 M | |
| Income Before Tax | -8.6 M | -9 M | |
| Net Loss | -8.6 M | -9 M | |
| Total Other Income Expense Net | 234.6 K | 246.3 K | |
| Income Tax Expense | -11 M | -10.4 M | |
| Net Loss | -11 M | -11.5 M | |
| Non Operating Income Net Other | -8.5 M | -8.1 M | |
| Net Loss | -17 M | -17.8 M | |
| Interest Income | 420.3 K | 555.8 K | |
| Net Interest Income | 537 K | 563.9 K | |
| Change To Netincome | 1 M | 952.5 K | |
| Net Loss | (2.36) | (2.47) | |
| Income Quality | 1.01 | 0.61 | |
| Net Income Per E B T | 0.81 | 0.72 |
Pulmatrix Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Pulmatrix. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Pulmatrix position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Pulmatrix's important profitability drivers and their relationship over time.
Pulmatrix Earnings per Share Projection vs Actual
Use Pulmatrix in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Pulmatrix position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pulmatrix will appreciate offsetting losses from the drop in the long position's value.Pulmatrix Pair Trading
Pulmatrix Pair Trading Analysis
The ability to find closely correlated positions to Pulmatrix could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Pulmatrix when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Pulmatrix - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Pulmatrix to buy it.
The correlation of Pulmatrix is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Pulmatrix moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Pulmatrix moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Pulmatrix can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Pulmatrix position
In addition to having Pulmatrix in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Broad Debt ETFs Thematic Idea Now
Broad Debt ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Broad Debt ETFs theme has 301 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Broad Debt ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Your Equity Center. To learn how to invest in Pulmatrix Stock, please use our How to Invest in Pulmatrix guide.You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
To fully project Pulmatrix's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Pulmatrix at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Pulmatrix's income statement, its balance sheet, and the statement of cash flows.